Decellularized Muscle Supports New Muscle Fibers and Improves Function Following Volumetric Injury
Authors:
- Michael James McClureMichael James McClure
- David Josh CohenDavid Josh Cohen
- Allison N. RameyARAllison N. Ramey
- Caroline B. BivensCBCaroline B. Bivens
- Satya MalluSMSatya Mallu
- Jonathan E. IsaacsJIJonathan E. Isaacs
- Emily ImmingEIEmily Imming
- Yen-Chen HuangYHYen-Chen Huang
- MoonHae SunwooMSMoonHae Sunwoo
- Zvi SchwartzZvi Schwartz
- Barbara D. BoyanBBBarbara D. Boyan
- 27 March 2018
- journal article
- research article
- Published by SAGE Publications in Tissue Engineering Part A
- Vol. 24 (15-16) , 1228-1241
Abstract
Current strategies to treat volumetric muscle loss use primarily pedicle or free muscle transfers, but these grafts fail to adequately regenerate functional tissue. Decellularized soft tissue grafts possess physical and chemical cues to promote muscle regeneration, suggesting their potential for use in large muscle defects. In this study, we developed a decellularized muscle matrix (DMM) graft using rat gastrocnemius. Anisotropy and chemical components of the extracellular matrix were retained, including laminin, fibronectin, and collagen. We compared the ability of DMM, autologous muscle grafts (clinical standard), and type I collagen plugs (negative control) to support muscle regeneration. DMM supported regeneration over a 56-day period in 1 × 1 cm and 1.5 × 1 cm gastrocnemius defects in rats. Muscle function tests demonstrated improved muscle recovery in rats with DMM grafts when compared to collagen. Histological sections were assessed using morphometrics and immunostaining. DMM supported muscle regeneration with less fibrosis and more de novo neuromuscular receptors than either autograft or collagen. Overall, our results indicate that DMM may be used as a muscle replacement graft based on its ability to improve muscle function recovery, promote muscle regeneration, and support new neuromuscular junctions.Keywords
This publication has 92 references indexed in Scilit:
- A Standardized Rat Model of Volumetric Muscle Loss Injury for the Development of Tissue Engineering TherapiesBioResearch Open Access, 2012
- Laminin-111 Protein Therapy Reduces Muscle Pathology and Improves Viability of a Mouse Model of Merosin-Deficient Congenital Muscular DystrophyThe American Journal of Pathology, 2012
- Biochemical and mechanical environment cooperatively regulate skeletal muscle regenerationThe FASEB Journal, 2012
- Structure and function of the skeletal muscle extracellular matrixMuscle & Nerve, 2011
- Functional skeletal muscle formation with a biologic scaffoldBiomaterials, 2010
- Laminin‐332–β1 integrin interactions negatively regulate invadopodiaJournal of Cellular Physiology, 2009
- 3D Timelapse Analysis of Muscle Satellite Cell MotilityStem Cells, 2009
- Laminin Nanofiber Meshes That Mimic Morphological Properties and Bioactivity of Basement MembranesTissue Engineering Part C: Methods, 2009
- Engineered skeletal muscle tissue networks with controllable architectureBiomaterials, 2009
- MicroRNA-206: The skeletal muscle-specific myomiRBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2008